These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8987805)

  • 21. D2 receptor binding in dopa-responsive dystonia.
    Künig G; Leenders KL; Antonini A; Vontobel P; Weindl A; Meinck HM
    Ann Neurol; 1998 Nov; 44(5):758-62. PubMed ID: 9818931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
    Thobois S; Guillouet S; Broussolle E
    Neurophysiol Clin; 2001 Oct; 31(5):321-40. PubMed ID: 11817273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific binding of 3N-(2'-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET.
    Moerlein SM; Perlmutter JS
    Neurosci Lett; 1992 Dec; 148(1-2):97-100. PubMed ID: 1300511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone.
    Kaasinen V; Ruottinen HM; Någren K; Lehikoinen P; Oikonen V; Rinne JO
    J Nucl Med; 2000 Jan; 41(1):65-70. PubMed ID: 10647606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia.
    Turjanski N; Bhatia K; Burn DJ; Sawle GV; Marsden CD; Brooks DJ
    Neurology; 1993 Aug; 43(8):1563-8. PubMed ID: 8351012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans.
    Antenor-Dorsey JA; Markham J; Moerlein SM; Videen TO; Perlmutter JS
    Nucl Med Biol; 2008 Apr; 35(3):335-41. PubMed ID: 18355689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striatal dopaminergic system in dopa-responsive dystonia: a multi-tracer PET study shows increased D2 receptors.
    Rinne JO; Iivanainen M; Metsähonkala L; Vainionpää L; Pääkkönen L; Någren K; Helenius H
    J Neural Transm (Vienna); 2004 Jan; 111(1):59-67. PubMed ID: 14714216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.
    Tolosa E; Martí MJ
    Adv Neurol; 1988; 49():73-84. PubMed ID: 3278555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET imaging studies of dopamine D2 receptors: comparison of [18F]N-methylspiperone and the benzamide analogues [18F]MABN and [18F]MBP in baboon brain.
    Mach RH; Ehrenkaufer RL; Greenberg JH; Shao L; Morton TE; Evora PH; Nowak PA; Luedtke RR; Cohen D; Reivich M
    Synapse; 1995 Mar; 19(3):177-87. PubMed ID: 7784958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of endogenous dopamine on measures of [18F]N-methylspiroperidol binding in the basal ganglia: comparison of simulations and experimental results from PET studies in baboons.
    Logan J; Dewey SL; Wolf AP; Fowler JS; Brodie JD; Angrist B; Volkow ND; Gatley SJ
    Synapse; 1991 Nov; 9(3):195-207. PubMed ID: 1685599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [PET study of dopamine metabolism and dopamine D2 receptor in juvenile parkinsonism].
    Tanji H; Nagasawa H; Itoh M; Itoyama Y
    Nihon Rinsho; 1997 Jan; 55(1):89-94. PubMed ID: 9014428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and in vivo evaluation of [18F]-N-(p-nitrobenzyl)spiperone ([18F]PNBS) in rats.
    Mach RH; Nowak PA; Moroney DA; Morton TE; Jackson JR; Ehrenkaufer RL
    Nucl Med Biol; 1993 Apr; 20(3):269-78. PubMed ID: 8485486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative autoradiography reveals regionally selective changes in dopamine D1 and D2 receptor binding in the genetically dystonic hamster.
    Nobrega JN; Richter A; Tozman N; Jiwa D; Löscher W
    Neuroscience; 1996 Apr; 71(4):927-37. PubMed ID: 8684623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem-thalamic lesion: structural and functional abnormalities studied with CT, MRI, and PET scanning.
    Leenders KL; Frackowiak RS; Quinn N; Brooks D; Sumner D; Marsden CD
    Mov Disord; 1986; 1(1):51-8. PubMed ID: 2973558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
    Nurmi E; Bergman J; Eskola O; Solin O; Vahlberg T; Sonninen P; Rinne JO
    Synapse; 2003 Jun; 48(3):109-15. PubMed ID: 12645035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET measurements of dopaminergic pathways in the brain.
    Perlmutter JS; Moerlein SM
    Q J Nucl Med; 1999 Jun; 43(2):140-54. PubMed ID: 10429509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.
    Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL
    Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The problem of adult-onset idiopathic torsion dystonia and other isolated dyskinesias in adult life (including blepharospasm, oromandibular dystonia, dystonic writer's cramp, and torticollis, or axial dystonia).
    Marsden CD
    Adv Neurol; 1976; 14():259-76. PubMed ID: 941774
    [No Abstract]   [Full Text] [Related]  

  • 40. Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol.
    Karbe H; Wienhard K; Hamacher K; Huber M; Herholz K; Coenen HH; Stöcklin G; Lövenich A; Heiss WD
    J Neural Transm Gen Sect; 1991; 86(3):163-73. PubMed ID: 1837996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.